Respiratory syncytial virus (RSV) is the leading cause of infant bronchiolitis. The closely related pneumonia virus of mice (PVM) causes a similar immune-mediated disease in mice, which allows an analysis of host factors that lead to severe illness. This project was designed to compare the immune responses to lethal and sublethal doses of PVM strain 15 in Balb/c and C57Bl/6 mice. Balb/c mice responded to PVM infection with an earlier and stronger innate response that failed to control viral replication. Production of inflammatory cyto- and chemokines, as well as infiltration of neutrophils and IFN-γ secreting natural killer cells into the lungs, was more predominant in Balb/c mice. In contrast, C57Bl/6 mice were capable of suppressing both viral replication and innate inflammatory responses. After a sublethal infection, PVM-induced IFN-γ production by splenocytes was stronger early during infection and weaker at late time points in C57Bl/6 mice when compared to Balb/c mice. Furthermore, although the IgG levels were similar and the mucosal IgA titres lower, the virus neutralizing antibody titres were higher in C57Bl/6 mice than in Balb/c mice. Overall, the difference in susceptibility of these two strains appeared to be related not to an inherent T helper bias, but to the capacity of the C57Bl/6 mice to control both viral replication and the immune response elicited by PVM.
References
[1]
Bonville, C.A.; Bennett, N.J.; Koehnlein, M.; Haines, D.M.; Ellis, J.A.; DelVecchio, A.M; Rosenberg, H.F.; Domachowske, J.B. Respiratory dysfunction and proinflammatory chemokines in the pneumonia virus of mice (PVM) model of viral bronchiolitis. Virology 2006, 349, 87–95, doi:10.1016/j.virol.2006.02.017.
[2]
Rosenberg, H.F.; Bonville, C.A.; Easton, A.J.; Domachowske, J.B. The pneumonia virus of mice infection model for severe respiratory syncytial virus infection: Identifying novel targets for therapeutic intervention. Pharmacol. Ther. 2005, 105, 1–6, doi:10.1016/j.pharmthera.2004.09.001.
[3]
El-Hajje, M.J.; Lambe, C.; Moulin, F.; Suremain, N.; Pons-Catalano, C.; Chalumeau, M.; Raymond, J.; Lebon, P.; Gendrel, D. The burden of respiratory viral disease in hospitalized children in Paris. Eu. Eur. J. Pediatr. 2008, 167, 435–436, doi:10.1007/s00431-007-0529-5.
[4]
Deshpande, S.A.; Northern, V. The clinical and health economic burden of respiratory syncytial virus disease among children under 2 years of age in a defined geographical area. Arch. Dis. Child 2003, 88, 1065–1069, doi:10.1136/adc.88.12.1065.
[5]
Iwane, M.K.; Edwards, K.M.; Szilagyi, P.G.; Walker, F.J.; Griffin, M.R.; Weinberg, G.A.; Coulen, C.; Poehling, K.A.; Shone, L.P.; Balter, S.; et al. Population-based surveillance for hospitalizations associated with respiratory syncytial virus, influenza virus, and parainfluenza viruses among young children. Pediatrics 2004, 113, 1758–1764, doi:10.1542/peds.113.6.1758.
[6]
Glezen, W.P.; Taber, L.H.; Frank, A.L.; Kasel, J.A. Risk of primary infection and reinfection with respiratory syncytial virus. Am. J. Dis. Child 1986, 140, 543–546.
[7]
Hall, C.B. Respiratory syncytial virus: its transmission in the hospital environment. Yale J. Biol. Med. 1982, 55, 219–223.
[8]
Welliver, R.C. Review of epidemiology and clinical risk factors for severe respiratory syncytial virus (RSV) infection. J. Pediatrics 2003, 143, 112–117, doi:10.1067/S0022-3476(03)00508-0.
[9]
Openshaw, P.J.; Tregoning, J.S. Immune responses and disease enhancement during respiratory syncytial virus infection. Clin. Microbiol. Rev. 2005, 18, 541–555.
[10]
Byrd, L.G.; Prince, G.A. Animal models of respiratory syncytial virus infection. Clin. Infect. Dis. 1997, 25, 1363–1368.
Anh, D.B.; Faisca, P.; Desmecht, D.J. Differential resistance/susceptibility patterns to pneumovirus infection among inbred mouse strains. Am. J. Physiol. Lung Cell. Mol. Physiol. 2006, 291, L426–435, doi:10.1152/ajplung.00483.2005.
[13]
Rosenberg, H.F.; Domachowske, J.B. Pneumonia virus of mice: severe respiratory infection in a natural host. Immunol. Lett. 2008, 118, 6–12, doi:10.1016/j.imlet.2008.03.013.
[14]
Krempl, C.D.; Lamirande, E.W.; Collins, P.L. Complete sequence of the RNA genome of pneumonia virus of mice (PVM). Virus Gene. 2005, 30, 237–249, doi:10.1007/s11262-004-5631-4.
[15]
Domachowske, J.B.; Bonville, C.A.; Easton, A.J.; Rosenberg, H.F. Differential expression of proinflammatory cytokine genes in vivo in response to pathogenic and nonpathogenic pneumovirus infections. J. Infect. Dis. 2002, 186, 8–14, doi:10.1086/341082.
[16]
Krempl, C.D.; Collins, P.L. Reevaluation of the virulence of prototypic strain 15 of pneumonia virus of mice. J. Virol. 2004, 78, 13362–13365, doi:10.1128/JVI.78.23.13362-13365.2004.
[17]
Horsfall, F.L.; Hahn, R.G. A latent virus in normal mice capable of producing pneumonia in its natural host. J. Exp. Med. 1940, 71, 391–408, doi:10.1084/jem.71.3.391.
[18]
Kuroda, E.; Kito, T.; Yamashita, U. Reduced expression of STAT4 and IFN-gamma in macrophages from BALB/c mice. J. Immunol. 2002, 168, 5477–5482.
[19]
Launois, P.; Swihart, K.G.; Milon, G.; Louis, J.A. Early production of IL-4 in susceptible mice infected with Leishmania major rapidly induces IL-12 unresponsiveness. J. Immunol. 1997, 158, 3317–3324.
[20]
Liu, T.; Matsuguchi, T.; Tsuboi, N.; Yajima, T.; Yoshikai, Y. Differences in expression of toll-like receptors and their reactivities in dendritic cells in BALB/c and C57BL/6 mice. Infect. Immun. 2002, 70, 6638–6645, doi:10.1128/IAI.70.12.6638-6645.2002.
[21]
Scharton-Kersten, T.; Afonso, L.C.; Wysocka, M.; Trinchieri, G.; Scott, P. IL-12 is required for natural killer cell activation and subsequent T helper 1 cell development in experimental leishmaniasis. J. Immunol. 1995, 154, 5320–5330.
[22]
Srikiatkhachorn, A.; Chang, W.; Braciale, T.J. Induction of Th-1 and Th-2 responses by respiratory syncytial virus attachment glycoprotein is epitope and major histocompatibility complex independent. J. Virol. 1999, 73, 6590–6597.
[23]
Srikiatkhachorn, A.; Braciale, T.J. Virus-specific CD8+ T lymphocytes downregulate T helper cell type 2 cytokine secretion and pulmonary eosinophilia during experimental murine respiratory syncytial virus infection. J. Exp. Med. 1997, 186, 421–432, doi:10.1084/jem.186.3.421.
[24]
Garvey, T.L.; Dyer, K.D.; Ellis, J.A.; Bonville, C.A.; Foster, B.; Prussin, C.; Easton, A.J.; Domachowske, J.B.; Rosenberg, H.F. Inflammatory responses to pneumovirus infection in IFN-alpha beta R gene-deleted mice. J. Immunol. 2005, 175, 4735–4744.
[25]
Bonville, C.A.; Lau, V.K.; DeLeon, J.M.; Gao, J.L.; Easton, A.J.; Rosenberg, H.F.; Domachowske, J.B. Functional antagonism of chemokine receptor CCR1 reduces mortality in acute pneumovirus infection in vivo. J. Virol. 2004, 78, 7984–7089, doi:10.1128/JVI.78.15.7984-7989.2004.
[26]
Domachowske, J.B.; Bonville, C.A.; Gao, J.L.; Murphy, P.M.; Easton, A.J.; Rosenberg, H.F. The chemokine macrophage-inflammatory protein-1 alpha and its receptor CCR1 control pulmonary inflammation and antiviral host defense in paramyxovirus infection. J. Immunol. 2000, 165, 2677–2682.
[27]
Bonville, C.A.; Easton, A.J.; Rosenberg, H.F.; Domachowske, J.B. Altered pathogenesis of severe pneumovirus infection in response to combined antiviral and specific immunomodulatory agents. J. Virol. 2003, 77, 1237–1244.
[28]
Bonville, C.A.; Bennett, N.J.; Percopo, C.M.; Branigan, P.J.; Del Vecchio, A.M.; Rosenberg, H.F.; Domachowske, J.B. Diminished inflammatory responses to natural pneumovirus infection among older mice. Virology 2007, 368, 182–190, doi:10.1016/j.virol.2007.06.020.
[29]
Domachowske, J.B.; Bonville, C.A.; Dyer, K.D.; Easton, A.J.; Rosenberg, H.F. Pulmonary Eosinophilia and Production of MIP-1[alpha] Are Prominent Responses to Infection with Pneumonia Virus of Mice. Cellular Immunol. 2000, 200, 98–104, doi:10.1006/cimm.2000.1620.
[30]
Rigaux, P.; Killoran, K.E.; Qiu, Z.; Rosenberg, H.F. Depletion of alveolar macrophages prolongs survival in response to acute pneumovirus infection. Virology 2012, 422, 338–345, doi:10.1016/j.virol.2011.10.031.
[31]
Noah, T.L.; Becker, S. Chemokines in nasal secretions of normal adults experimentally infected with respiratory syncytial virus. Clin. Immunol. 2000, 97, 43–49, doi:10.1006/clim.2000.4914.
[32]
Sheeran, P.; Jafri, H.; Carubelli, C.; Saavedra, J.; Johnson, C.; Krisher, K.; Sánchez, P.J.; Ramilo, O. Elevated cytokine concentrations in the nasopharyngeal and tracheal secretions of children with respiratory syncytial virus disease. Pediatr. Infect. Dis. J. 1999, 18, 115–122, doi:10.1097/00006454-199902000-00007.
[33]
Abu-Harb, M.; Bell, F.; Finn, A.; Rao, W.H.; Nixon, L.; Shale, D.; Everard, M.L. IL-8 and neutrophil elastase levels in the respiratory tract of infants with RSV bronchiolitis. Eur. Resp. J. 1999, 14, 139–143, doi:10.1034/j.1399-3003.1999.14a23.x.
[34]
Bont, L.; Heijnen, C.J.; Kavelaars, A.; van Aalderen, W.M.; Brus, F.; Draaisma, J.T.; Geelen, S.M.; van Vught, H.J. Peripheral blood cytokine responses and disease severity in respiratory syncytial virus bronchiolitis. Eur. Respir. J. 1999, 14, 144–149, doi:10.1034/j.1399-3003.1999.14a24.x.
Claassen, E.A.W.; van der Kant, P.A.A.; Rychnavska, Z.S.; van Bleek, G.M.; Easton, A.J.; van der Most, R.G. Activation and Inactivation of Antiviral CD8 T Cell Responses during Murine Pneumovirus Infection. J. Immunol. 2005, 175, 6597–604.
[37]
Biron, C.A.; Nguyen, K.B.; Pien, G.C.; Cousens, L.P.; Salazar-Mather, T.P. Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annual Rev. Immunol. 1999, 17, 189–220, doi:10.1146/annurev.immunol.17.1.189.
[38]
Campbell, J.J.; Qin, S.; Unutmaz, D.; Soler, D.; Murphy, K.E.; Hodge, M.R.; Wu, L.; Butcher, EC. Unique subpopulations of CD56+ NK and NK-T peripheral blood lymphocytes identified by chemokine receptor expression repertoire. J. Immunol. 2001, 166, 6477–6482.
[39]
Moretta, A. Natural killer cells and dendritic cells: rendezvous in abused tissues. Nat. Rev. Immunol. 2002, 2, 957–964, doi:10.1038/nri956.
[40]
Li, F.; Zhu, H.; Sun, R.; Wei, H.; Tian, Z. Natural killer cells are involved in acute lung immune injury caused by respiratory syncytial virus infection. J. Virol. 2012, 86, 2251–2258, doi:10.1128/JVI.06209-11.
[41]
van Helden, M.J.; van Kooten, P.J.; Bekker, C.P.; Grone, A.; Topham, D.J.; Easton, A.J.; Boog, C.J.; Busch, D.H.; Zaiss, D.M.; Sijts, A.J. Pre-existing virus-specific CD8(+) T-cells provide protection against pneumovirus-induced disease in mice. Vaccine 2012, 30, 6382–6388, doi:10.1016/j.vaccine.2012.08.027.
[42]
Morton, D.B.; Griffiths, P.H. Guidelines on the recognition of pain, distress and discomfort in experimental animals and an hypothesis for assessment. Vet. Rec. 1985, 116, 431–436.
[43]
Labiuk, S.L.; Babiuk, L.A.; van Drunen Littel-van den Hurk, S. Major tegument protein VP8 of bovine herpesvirus 1 is phosphorylated by viral US3 and cellular CK2 protein kinases. J. Gen. Virol. 2009, 90, 2829–2839, doi:10.1099/vir.0.013532-0.
[44]
Park, J.K.; Cho, K.; Johnson, J.; Perez, R.V. Induction of MIP-1alpha in Kupffer cell by portal venous transfusion. Transplant. Immunol. 2004, 13, 33–38, doi:10.1016/j.trim.2004.02.001.
[45]
Vogel, C.F.; Nishimura, N.; Sciullo, E.; Wong, P.; Li, W.; Matsumura, F. Modulation of the chemokines KC and MCP-1 by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in mice. Arch. Biochem. Biophys. 2007, 461, 169–175, doi:10.1016/j.abb.2007.01.015.
[46]
Overbergh, L.; Giulietti, A.; Valckx, D.; Decallonne, R.; Bouillon, R.; Mathieu, C. The use of real-time reverse transcriptase PCR for the quantification of cytokine gene expression. J. Biomol. Tech. 2003, 14, 33–43.
[47]
Pascual, M.; Fernandez-Lizarbe, S.; Guerri, C. Role of TLR4 in ethanol effects on innate and adaptive immune responses in peritoneal macrophages. Immunol. Cell Biol. 2011, 89, 716–727, doi:10.1038/icb.2010.163.
[48]
Mapletoft, J.W.; Latimer, L.; Babiuk, L.A.; van Drunen Littel-van den Hurk, S. Intranasal immunization of mice with a bovine respiratory syncytial virus vaccine induces superior immunity and protection compared to those by subcutaneous delivery or combinations of intranasal and subcutaneous prime-boost strategies. Clin. Vaccine Immunol. 2010, 17, 23–35, doi:10.1128/CVI.00250-09.
[49]
Dyer, K.D.; Percopo, C.M.; Fischer, E.R.; Gabryszewski, S.J.; Rosenberg, H.F. Pneumoviruses infect eosinophils and elicit MyD88-dependent release of chemoattractant cytokines and interleukin-6. Blood 2009, 114, 2649–2656.
[50]
Heinze, B.; Frey, S.; Mordstein, M.; Schmitt-Graff, A.; Ehl, S.; Buchholz, U.J.; Collins, P.L.; Staeheli, P.; Krempl, C.D. Both nonstructural proteins NS1 and NS2 of pneumonia virus of mice are inhibitors of the interferon type I and type III responses in vivo. J. Virol. 2011, 85, 4071–4084.
[51]
Atochina, E.N.; Beers, M.F.; Tomer, Y.; Scanlon, S.T.; Russo, S.J.; Panettieri, R.A., Jr.; Haczku, A. Attenuated allergic airway hyperresponsiveness in C57BL/6 mice is associated with enhanced surfactant protein (SP)-D production following allergic sensitization. Respir. Res. 2003, 4, 15, doi:10.1186/1465-9921-4-15.
[52]
Rodriguez-Martinez, S.; Cancino-Diaz, M.E.; Jimenez-Zamudio, L.; Garcia-Latorre, E.; Cancino-Diaz, J.C. TLRs and NODs mRNA expression pattern in healthy mouse eye. British J. Ophthalmol. 2005, 89, 904–910, doi:10.1136/bjo.2004.056218.
[53]
Glineur, S.; Tran Anh, D.B.; Sarlet, M.; Michaux, C.; Desmecht, D. Characterization of the resistance of SJL/J mice to pneumonia virus of mice, a model for infantile bronchiolitis due to a respiratory syncytial virus. PloS One 2012, 7, e44581.
